SIGASIGA Technologies, Inc.Healthcare · Drug Manufacturers - Specialty & Genericas of 2026-09-16
Horizon

Issued 2026-09-16 at $3.10 · now $3.10 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, SIGA has typically landed between $2.44 and $4.08 — a range of −21.4% to +31.5% from the issuance price $3.10.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

5,001 overlapping 1 month windows · 2006-09-262026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($3.10) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where SIGA has typically landed a month from the 2026-09-16 close of $3.1 — the range is history, not a prediction.

$2.44worst · -21.4%$4.08best · +31.5%
  • now $3.1 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $3.08 (-0.8%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $2.8$3.35
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $2.44$4.08
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,001 windows spanning 2006-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2022-08-19−53.1%−53.1%+0.0%
2022-08-17−52.3%−52.3%+0.0%
2014-08-05−52.1%−53.1%+1.7%
3 best
2016-06-22+176.4%+0.0%+176.4%
2016-06-24+164.0%+0.0%+176.4%
2016-06-21+161.4%−5.4%+161.4%

5,001 overlapping windows · 2006-09-262026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
50%
+0.3%
n=20
Feb
55%
+10.7%
n=20
Mar
35%
+0.7%
n=20
Apr
55%
+9.4%
n=20
May
60%
+1.7%
n=20
Jun
50%
−3.2%
n=20
Jul
60%
+10.9%
n=20
Aug
50%
−0.5%
n=20
Sep
65%
−1.1%
n=20
Oct
30%
+4.7%
n=20
Nov
45%
−0.6%
n=20
Dec
50%
−1.0%
n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$8$3↑ buys↓ sales
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

110 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-06-09Nemirovsky JuliandirectorDisposition7,23573,754Form 4
2026-06-09Phillips Holly L.directorDisposition7,23573,754Form 4
2026-06-09KEANE JOHN MdirectorDisposition7,23516,881Form 4
2026-06-09Marshall Joseph W IIIdirectorDisposition7,235246,523Form 4
2026-06-09DURNAN JAYMIE AdirectorDisposition7,23588,754Form 4
2026-06-09Nabel Gary J.directorDisposition7,23573,754Form 4
2026-06-09Ford Harold Eugene Jr.directorDisposition7,23547,538Form 4
2026-06-09Ford Harold Eugene Jr.directorAward / grant34,16934,169Form 4
2026-06-09DURNAN JAYMIE AdirectorOption exercise24,1160Form 4
2026-06-09Nabel Gary J.directorOption exercise24,1160Form 4
2026-06-09KEANE JOHN MdirectorOption exercise24,1160Form 4
2026-06-09KEANE JOHN MdirectorAward / grant34,16934,169Form 4
2026-06-09DURNAN JAYMIE AdirectorAward / grant34,16934,169Form 4
2026-06-09Nabel Gary J.directorAward / grant34,16934,169Form 4
2026-06-09Marshall Joseph W IIIdirectorOption exercise24,1160Form 4
2026-06-09Nemirovsky JuliandirectorOption exercise24,1160Form 4
2026-06-09Nemirovsky JuliandirectorAward / grant34,16934,169Form 4
2026-06-09Ford Harold Eugene Jr.directorOption exercise24,1160Form 4
2026-06-09Marshall Joseph W IIIdirectorAward / grant34,16934,169Form 4
2026-06-09Phillips Holly L.directorOption exercise24,1160Form 4
2026-06-09Phillips Holly L.directorAward / grant34,16934,169Form 4
2026-06-09Marshall Joseph W IIIdirectorOption exercise24,116253,758Form 4
2026-06-09Ford Harold Eugene Jr.directorOption exercise24,11654,773Form 4
2026-06-09KEANE JOHN MdirectorOption exercise24,11624,116Form 4
2026-06-09DURNAN JAYMIE AdirectorOption exercise24,11695,989Form 4
2026-06-09Nabel Gary J.directorOption exercise24,11680,989Form 4
2026-06-09Nemirovsky JuliandirectorOption exercise24,11680,989Form 4
2026-06-09Phillips Holly L.directorOption exercise24,11680,989Form 4
2026-06-09Nabel Gary J.directorOption exercise24,11680,989Form 4
2026-06-09DURNAN JAYMIE AdirectorOption exercise24,11695,989Form 4
2026-06-09Nemirovsky JuliandirectorOption exercise24,11680,989Form 4
2026-06-09Phillips Holly L.directorOption exercise24,11680,989Form 4
2026-06-09Ford Harold Eugene Jr.directorOption exercise24,11654,773Form 4
2026-06-09KEANE JOHN MdirectorOption exercise24,11624,116Form 4
2026-06-09Marshall Joseph W IIIdirectorOption exercise24,116253,758Form 4
2026-03-25Miller Larry R.officerWithheld for tax3,52651,912Form 4
2026-03-25Miller Larry R.officerOption exercise6,92055,438Form 4
2026-03-25Miller Larry R.officerOption exercise6,9206,921Form 4
2026-03-13Nguyen DiemdirectorWithheld for tax47,029138,767Form 4
2026-03-13Miller Larry R.officerWithheld for tax11,18748,518Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.